Does ENASIDENIB Cause Neutrophil count abnormal? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Neutrophil count abnormal have been filed in association with ENASIDENIB (Idhifa). This represents 0.3% of all adverse event reports for ENASIDENIB.
11
Reports of Neutrophil count abnormal with ENASIDENIB
0.3%
of all ENASIDENIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Neutrophil count abnormal From ENASIDENIB?
Of the 11 reports, 1 (9.1%) resulted in death.
Is Neutrophil count abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
What Other Drugs Cause Neutrophil count abnormal?
CLOZAPINE (232)
PEGFILGRASTIM (221)
LENALIDOMIDE (170)
PALBOCICLIB (102)
VENETOCLAX (98)
DEXAMETHASONE (97)
CYCLOPHOSPHAMIDE (74)
RIBOCICLIB (74)
IXAZOMIB (64)
RITUXIMAB (64)
Which ENASIDENIB Alternatives Have Lower Neutrophil count abnormal Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ